Cervical Cancer

HPV Vaccine Deemed Safe Despite Higher Anaphylaxis Rates
According to a study published in CMAJ, young women who had human papillomavirus (HPV) vaccination were found to be five to twenty times more likely to have anaphylaxis than women identified in comparable school-based vaccination programs. Researchers, however, also considered the overall rates of anaphylaxis to be low with no serious lasting effects.